A HARSH DECREE: Everything may die, nothing may be regenerated

A HARSH DECREE Everything may die, nothing may be regenerated ARTICLE EXTRAS1 "I think it really was a turning point in the acceptance of the phenomenon as being real," Gould says. In the late 1990s Gould observed neurogenesis in the adult tree shrew as well,2 but the question remained: Did it occur in humans? "For us to believe it's more than an epiphenomenon, we needed to see if it occurs in humans," Gage s

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Everything may die, nothing may be regenerated

ARTICLE EXTRAS

Fortunately, the experiment was essentially already set up. Some cancer patients received BrdU injections to check for dividing cells in tumor biopsies. Gage sent requests for brains to every pathologist he knew. When the brains arrived they were brought to the microscope room and indeed, BrdU lit up the confocal with labeled cells in the hippocampus and cortex. But the problem was in determining whether these cells were neurons. Double-labeling them with neuronal or glial markers was impossible because the tissue was fixed in paraffin.

The clinicians in Gage's lab were determined to figure out whether neurogenesis occurs in humans. Peter Eriksson, who had taken a sabbatical at the Salk, returned to the Sahlgrenska University Hospital in Göteborg, Sweden, and gained permission from cancer patients injected with BrdU to use their brains once they died. Five brains, properly fixed and double- ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies